Concept of Artificial Intelligence in Discovering and Re-Purposing of Drugs

Abstract

Artificial Intellignece (AI) is a platform lending immense assistance in discovering and developing drugs and thus, various such approaches have been developed with the intent of simplifying and improving biomedical operations such as drug repurposing and drug discovery. In the past decade, AI-based investigation of nanomedicines, as well as non-nanomedicines has reached the clinical level. In semblance with the traditional methods of therapy, nanomedicine therapy is employed at limited doses. The study of a variety of drugs resulted in the conclusion that the effect of each drug is variable for every patient and, evaluating that perfect drug combination manually is a time-consuming as well as an inefficient treatment method. Therefore, the use of AI simplifies and reduces the time consumption in determining the perfect customized drug combination for nano-therapy. The area with the most potential for meeting this reality is to optimize the drug and dosage parameters. It is a universally known fact that cancer is dangerous and unique because of the exacting challenges it poses during treatment and, to achieve a better treatment, the therapeutic effect on each patient must be delineated even if the volume of data generated is massive. The article aims at analyzing the AI technologies that help yield results much quicker, make the analyses simple, and efficient.

A Simple, Stable, and Highly Sensitive Spectrophotometric Method for the Determination of Arsenic(III) from Different Biological Media in the Presence of Nanosilica-Cysteine Composite

“…Iodine that has been released oxidizes the dye, which results in colour development. Modified silica nanoparticles find wide use as supports of catalytic systems, fillers in the production of nanocomposites, optical electronic devices, electrochemical sensors, photonics (26), and also in drug delivery (27). Silica particles with a hydrophilic surface layer are biologically inert, which determines their promising use in medicine and biotechnology (27).…”

“…However, nanotechnology in the biomedical and environmental domains has vastly increased the chances of integrating various inorganic metals (i.e. arsenic) due to the help of adsorption and binding forces (27). But the problem is dealing with this irritated nano-system while the determination of the focused ion/s.…”